Ali Azim in Southaven, Mississippi

Home Mississippi Southaven

Ali Azim has Pulmonary Disease as his primary medical specialty. Their primary office is: 363 Southcrest Cir in Southaven, Mississippi.

They're a part of the: Memphis Lung Physicians Foundation, Inc. medical group which has around 45 members. You can call their office at 662-349-0488 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2012 (around 12 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Ali Azim Office Phone and Directions

Ali Azim
Memphis Lung Physicians Foundation, Inc.
363 Southcrest Cir
Southaven, Mississippi 38671
662-349-0488

Patient Ratings
Please rate your experience with Ali Azim below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 662-349-0488

Enter a starting address:

Healthcare Info for Ali Azim

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS), SLEEP MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 2012
The Primary Medical Specialty for Ali Azim is listed as: Pulmonary Disease
Approximate Years of Experience: 12
PAC (PECOS ID)#: 4981997848
NPI #: 1780035030
NPI Created On: 06/28/2016
NPI Last Updated Listed as: 07/22/2022
Primary Taxonomy Code: 207RC0200X
License Number:
29661
Listed Gender: Male

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Informational Meal

Record ID:: 830041463

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Respiratory

Name of Drug #1: FASENRA

Open Associated Drug #1: 0310-1730-30